Regeneron Pharmaceuticals...

AI Score

0
XX

Unlock

686.12
1.41 (0.21%)
At close: Jan 28, 2025, 2:02 PM

Regeneron Pharmaceuticals Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
Collaboration Revenue Revenue 1.66B 1.52B 1.27B 1.37B 1.44B 1.32B 1.38B 0 1.05B 1.04B 1.23B 86.20M 1.07B 954.70M 754.40M 1.62B 1.48B 1.23B 1.24B 1.29B 1.24B 1.21B 1.10B 2.08B 1.03B 996.38M
Collaboration Revenue Revenue Growth +8.93% +20.30% -7.53% -4.75% +9.24% -4.46% n/a -100.00% +0.67% -15.33% +1329.81% -91.97% +12.49% +26.55% -53.48% +9.42% +20.81% -0.79% -3.86% +3.88% +2.74% +9.14% -47.01% +103.25% +2.92% n/a
Product and Service, Other Revenue 114.20M 104.50M 116.90M 212.50M 138.30M 69.30M 116.00M 127.70M 84.20M 59.20M 94.00M 3.98B 99.00M 46.00M 50.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Product and Service, Other Revenue Growth +9.28% -10.61% -44.99% +53.65% +99.57% -40.26% -9.16% +51.66% +42.23% -37.02% -97.64% +3915.35% +115.22% -8.00% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Product Revenue 1.95B 1.92B 1.76B 1.85B 1.79B 1.77B 1.67B 1.70B 1.80B 1.75B 1.64B n/a 2.28B 4.14B 1.72B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Product Revenue Growth +1.45% +8.93% -4.89% +3.68% +0.79% +6.24% -1.84% -5.67% +2.68% +7.07% n/a n/a -44.90% +139.97% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
United States Revenue 5.89B 6.89B 12.12B 5.57B 4.83B 4.11B
United States Revenue Growth -14.63% -43.11% +117.64% +15.17% +17.73% n/a
Rest Of World Revenue 324.30M 73.00M n/a n/a n/a n/a
Rest Of World Revenue Growth +344.25% n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 714.40M 758.80M 689.00M 737.70M 640.50M 652.00M 601.10M 660.50M 529.10M 476.30M 450.00M 559.60M 445.00M 414.70M 405.60M 303.50M 326.90M 348.30M 367.30M 586.80M 419.90M 417.30M 410.80M 491.30M 369.23M 364.88M 330.77M 409.91M 306.77M 306.91M 296.85M 325.94M 270.05M 292.04M 289.68M 294.95M 209.99M 174.59M 158.99M
Selling, General, and Administrative Revenue Growth -5.85% +10.13% -6.60% +15.18% -1.76% +8.47% -8.99% +24.83% +11.09% +5.84% -19.59% +25.75% +7.31% +2.24% +33.64% -7.16% -6.14% -5.17% -37.41% +39.75% +0.62% +1.58% -16.39% +33.06% +1.19% +10.31% -19.31% +33.62% -0.05% +3.39% -8.93% +20.70% -7.53% +0.82% -1.79% +40.46% +20.28% +9.81% n/a
Research and Development Revenue 1.27B 1.08B 1.13B 1.18B 1.08B 1.09B 1.10B 1.04B 911.30M 794.30M 843.80M 785.60M 665.40M 714.20M 742.90M 744.50M 684.60M 722.00M 583.90M 683.10M 663.40M 1.05B 641.80M 601.20M 556.97M 529.29M 498.59M 527.98M 529.75M 509.98M 507.44M 479.21M 543.05M 559.93M 470.11M 461.21M 425.92M 390.33M 343.11M
Research and Development Revenue Growth +17.81% -4.85% -3.64% +9.48% -0.92% -1.44% +5.57% +14.46% +14.73% -5.87% +7.41% +18.06% -6.83% -3.86% -0.21% +8.75% -5.18% +23.65% -14.52% +2.97% -36.72% +63.34% +6.75% +7.94% +5.23% +6.16% -5.57% -0.33% +3.88% +0.50% +5.89% -11.76% -3.02% +19.11% +1.93% +8.28% +9.12% +13.76% n/a

Create Price Alert on REGN

Your price alert will notify you when the stock price is above 686.12.

Add to Watchlist